1
www.pharmacy.gov.my
PHARMACEUTICAL SERVICES DIVISIONMinistry of Health MalaysiaLot 36, Jalan Universiti46350 Petaling JayaSelangor
T 03-7841 3200 F 03-7968 2222
PHARMACEUTICAL SERVICES DIVISIONMinistry of Health Malaysia
PHARMACYPROGRAMMESTRATEGIC PLAN
PHARMACY PROGRAMME STRATEGIC PLAN
2017-20202
1
The Ministry of Health is pleased to present the Pharmacy Programme Strategic Plan which sets into motion a four-year programme mapping the way forward. The plan outlines their strategic
vision supported by the core thrusts, strategies and initiatives that are synergistically moulded in order to achieve the mission and vision of the Pharmacy Programme.
The plan addresses the need to provide sustainable, high-quality pharmacy services in a complex and evolving environment. The plan clearly defines the direction of the Programme and sets priorities for action that can be implemented at national, regional and local levels.
The Pharmacy services play an integral role in the healthcare service delivery system. It offers a wide range of services spanning from primary and secondary care and enforcement of law that includes, but not limited to pharmaceutical products and cosmetics. The Pharmacy plan also supports the pharmaceutical industry by providing the regulatory backbone to ensure further growth and expansion of this vital and dynamic sector. Greater collaboration and cooperation between the various healthcare stakeholders will boost the country’s economy and improve quality of life for all.
I wish to sincerely acknowledge the dedication and effort of all who have participated in the development of this plan under the leadership of the Senior Director of the Pharmaceutical Services for the formulation of the 2017-2020 Pharmacy Programme Strategic Plan. I am certain that the success of the plan will have a positive impact on our robust healthcare system. Together we will strive towards improving the country’s healthcare needs.
DATUK DR. NOOR HISHAM BIN ABDULLAHDIRECTOR GENERAL OF HEALTHMINISTRY OF HEALTH MALAYSIA
FOREWORD
PHARMACY PROGRAMME STRATEGIC PLAN
2017-20202
The Eleventh Malaysia Plan (2016-2020) has mapped the last leg of our path to reach Vision 2020. Accordingly, the Ministry of Health (MOH) has charted the way forward for the nation’s health services
through the MOH Strategic Plan 2016-2020 as well as the Health Transformation Plan to support the national agenda in achieving better health for the nation.
It is imperative for us to develop our strategic plan to guide the organisation towards achieving a common goal. With the overarching National Medicines Policy, key strategies are drawn up by analysing the current situation, our strengths and weaknesses and projecting the future needs.
As part of the team that will carry out this mission, the Pharmaceutical Services Programme MOH is focused on intensifying customer engagement in order to reach a wider population and increasing public awareness on their roles and responsibilities towards health. From the organisation aspect, we will improve operational excellence where resources will be used optimally to ensure responsive, efficient service and effective policy implementation.
The Pharmaceutical Services Programme is committed to stay ahead and keep up with changing times. Implementation of innovative pharmacy service delivery and the strengthening of ICT system readiness will create value for the customers and enhance the future delivery of healthcare to the nation. Innovation in pharmacy services will be supported mainly by initiatives in ICT-based systems such as PhIS, MyPharma-C and Quest 3+ by the National Pharmacy Regulatory Agency. Translation of research findings into the development of policy and practice are crucial for efficient organisation management and ensuring subsequent actions taken by the Programme are beneficial to the nation. We will also commit to boosting capability building by focusing on skills and knowledge enhancement in new areas as well as developing expertise in various pharmacy fields.
I believe, with the collaborated effort from all, we will implement this plan successfully and overcome the challenges and issues in the future. Let us work together as a team to achieve better health for the nation.
DR. SALMAH BINTI BAHRI, RPh 783SENIOR DIRECTOR OF PHARMACEUTICAL SERVICES PROGRAMMEMINISTRY OF HEALTH MALAYSIA
FOREWORD
3
FOREWORD
The Pharmacy Programme Strategic Plan (2017-2020) is an important document that determines the direction of the Pharmacy Programme in carrying out its role in accordance with
the aspirations of the government. This strategic plan is an initial step to ensure the development of Pharmacy Programme which is in line with the government and the ministry’s mission and vision in strengthening the health system transformation.
The Strategic Plan focuses on four main aspects, namely strengthening the governance of Pharmacy Programme, strengthening service delivery through innovation and technology, strengthening the skills, expertise and human resource capacity, and enhancing cooperation with stakeholders and empowering communities on quality use of medicines. The strategies and initiatives outlined in this plan will also have an impact on the development of pharmacy services in the future. In carrying out this mission, every member of Pharmacy Programme should instil and uphold the shared values and leadership practices identified in this document.
Finally, I would like to extend my earnest appreciation to all parties involved in the realization of this strategic plan. I hope that every member of the Pharmacy Programme is fully committed to the success of this plan.
DR. RAMLI BIN ZAINAL, RPh 1045DIRECTOR OF PHARMACY POLICY AND STRATEGIC PLANNING DIVISIONMINISTRY OF HEALTH MALAYSIA
PHARMACY PROGRAMME STRATEGIC PLAN
2017-20204
The Pharmacy Programme of the Ministry of Health (MOH), established in 1951, is the lead agency that ensures the public gets access to safe, efficacious and quality pharmaceutical products, protecting their interest via enforcement of relevant legislations, and ensuring rational use of medicines by both healthcare providers and patients.
The Programme consists of five main divisions headed by a Senior Director of Pharmaceutical Services. These five main Divisions are Pharmacy Policy and Strategic Planning Division, Pharmacy Practice and Development Division, Pharmacy Enforcement Division, National Pharmaceutical Regulatory Agency (NPRA) and Pharmacy Board Malaysia. Each division plays important roles in different aspects and approaches with the same objective that is giving the best professional pharmacy service to the public.
Pharmacy Programme Strategic Plan 2017-2020 outlines the strategic directions of the Pharmacy Programme for a period of 4 years with four main focuses:
INTRODUCTION
5
MOH• Strengthen delivery of
healthcare (primary care)• Health system governance• Empowering community• Intensify collaboration
This strategic plan was developed with a view to the future direction of Pharmacy Programme in aligning with the needs and the current situation of the government’s plans. The fundamentals of this strategic plan are based on:
Strategic Thrust 2 of 11th Malaysia Plan
Improving well being for all• Priority focus area
is to achieve universal accessto quality healthcare
Health Services Transformation Plan (HSTP), Ministry of Health, Malaysia
• Developing talented health workforce
• Strengthening health policies and public organisational capacity
• Enhancing health services delivery
• Intensify health collaboration
• Inculcate corporate culture values
Ministry of Health (MOH) Strategic Plan
2016-2020• Strengthening the
healthcare service delivery especially in the primary healthcare
• Strengthening health systems governance and organisational capabilities
• Empowering individuals, families, the community toward better health awareness
• Intensify the collaboration between the public, private and NGO
Malaysian National Medicines Policy (MNMP),
2013-2020Malaysian National Medicines Policy (MNMP) objective is to promote equitable access and rational use of safe, effective and affordable essential medicines of good quality to improve health outcomes of the nations. Five core components in MNMP are:• Governance in Medicines• Access to Medicines• Quality, Safety and Efficacy
of Medicines• Quality Use of Medicines• Partnership and
Collaboration for the Healthcare Industry
A B C D
11th MALAYSIAN PLANAchieving universal access to quality healthcare
MNMPEquitable access & rational use of safe, effective & affordable medicines of good quality to improve health outcomes of the people
HSTP• Revitalising capability building• Re-engineering organisations• Enhancing service delivery• Intensify collaboration• Enculturing corporate culture
STRATEGIC PLANALIGNMENT
PHARMACY PROGRAMME STRATEGIC PLAN
2017-20206
PHARMACYENFORCEMENT
DIVISIONwe will
• Ensure all sales, supply, possession and advertising of
substances, products andcosmetics are in
compliance with thelegal provisions.
PHARMACYPRACTICE &
DEVELOPMENT DIVISIONwe will
• Ensure continuous access to the quality, safe and cost-effective medicines.
• Strengthen the quality and rational use of medicines towards the better health.
• Enhance pharmaceutical careservices in line with the good
standards and practices.
POISONS ACT 1952 • Poisons Regulations 1952• Poisons (Fees) Regulations 1983• Poisons (Psychotropic
Substances) Regulations 1989
SALE OF DRUGS ACT 1952• Control of Drugs
and Cosmetics Regulations 1984
REGISTRATION OF PHARMACISTS ACT 1951• Registration of Pharmacists
Regulations 2004
MEDICINES (ADVERTISEMENT AND SALE) ACT 1956• Medicine
Advertisements Board Regulations 1976
POISONS (SODIUM HYDROXIDE) REGULATIONS 1962
SALE OF DRUGS (CERTIFICATE OF ANALYSIS) REGULATIONS 1997
PHARMACYPOLICY & STRATEGICPLANNING DIVISION
we will• Develop policies for the
pharmaceutical sector in line with the needs of national healthcare.
• Ensure excellent and efficient resources management.
PHARMACYBOARD OF MALAYSIA
we will• Ensure the registration of pharmacists
and bodies corporate complies withRegistration of Pharmacists Act 1951
and its regulations.• Set the standard for conduct, ethics,
proficiency, education and trainingand Continuous Professional
Development (CPD).
NATIONALPHARMACY
REGULATORY AGENCYwe will
• Ensure that products approved for the local market are safe and of quality and also ensure that natural
products and cosmetics aresafe and of quality.
DIVISIONS’OBJECTIVES
RELATEDACTS ANDREGULATIONS
PHARMACY PROGRAMME STRATEGIC PLAN
2017-20206
7
OUR
VISI
ON
OUR
MIS
SION
4 ST
RATE
GIC
THRU
STS
Impl
emen
t inn
ovat
ive
phar
mac
y se
rvic
e de
liver
y
ICT-
base
d se
rvic
e in
nova
tion
Enha
nce
rese
arch
and
kn
owle
dge
shar
ing
Enha
nce
busi
ness
pro
cess
and
pr
oduc
t saf
ety
We
aim
to u
phol
d le
gisl
atio
ns a
nd im
prov
e po
licie
s to
en
sure
qua
lity
of p
harm
aceu
tical
pro
duct
s an
d se
rvic
esW
e ai
m to
ens
ure
effe
ctiv
e an
d re
spon
sive
org
anis
atio
nal
syst
em to
war
ds s
usta
inab
le q
ualit
y se
rvic
es
We
aim
to b
uild
cap
abili
ties
and
prof
essi
onal
ism
thro
ugh
tale
nt d
evel
opm
ent a
nd w
orkf
orce
em
pow
erm
ent
We
aim
to in
tens
ify c
olla
bora
tion
tow
ards
bes
t pra
ctic
es
and
stan
dard
s
Impr
ove
acce
ssib
ility
of
phar
mac
eutic
al p
rodu
cts
Impr
ove
effic
ienc
y an
d op
timis
e ex
pend
iture
Stre
ngth
en m
onito
ring
activ
ities
of
unre
gist
ered
pro
duct
s
Stre
ngth
en g
over
nanc
e an
d re
gula
tory
con
trol
Enha
nce
orga
nisa
tiona
l effi
cien
cy
Enha
nce
hum
an re
sour
ce
com
pete
ncy
and
perfo
rman
ce
Optim
ise
hum
an re
sour
ce
capa
city
to e
nsur
e co
ntin
uous
se
rvic
e de
liver
y
Enha
nce
mul
ti se
ctor
en
gage
men
t tow
ards
bet
ter
heal
th a
war
enes
s
Enha
nce
valu
e pr
opos
ition
of
phar
mac
y se
rvic
es
EFFI
CIEN
T
INNO
VATI
ON D
RIVE
NTr
ansl
atin
g id
eas
and
inno
vatio
ns in
to
serv
ice
that
cre
ates
val
ue fo
r our
cu
stom
ers.
OPER
ATIO
NAL
EXCE
LLEN
CETh
e el
emen
t of a
n or
gani
satio
nal
lead
ersh
ip th
at a
pplie
s a
varie
ty o
f pr
inci
ples
, sys
tem
s to
war
ds a
su
stai
nabl
e im
prov
emen
t of k
ey
perfo
rman
ce m
atrix
.
CAPA
BILI
TY B
UILD
INGS
Proc
ess
of d
evel
opin
g an
d st
reng
then
ing
the
skill
s, a
bilit
ies
and
reso
urce
s th
at
orga
nisa
tions
nee
d to
ada
pt a
nd th
rive
in a
cha
ngin
g en
viro
nmen
t.
CUST
OMER
ENG
AGEM
ENT
The
qual
ity o
f the
cus
tom
er
expe
rienc
e th
at e
mph
asis
es th
e po
sitiv
e as
pect
s of
the
inte
ract
ion
with
our
org
anis
atio
n.
TEAM
WOR
KCU
STOM
ER C
ARE
INTE
GRIT
YPR
OFES
SION
ALIS
ME
SHAR
ED V
ALUE
S
ENCO
URAG
E TH
EHE
ART
ENAB
LE O
THER
STO
ACT
CHAL
LENG
ETH
E PR
OCES
SIN
SPIR
E A
SHAR
ED V
ISIO
NM
ODEL
THE
WAY
LEAD
ERSH
IP P
RACT
ICES
To e
nhan
ce th
e na
tion’
s he
alth
thro
ugh
exce
llenc
e in
the
prac
tice
of p
harm
acy
7PH
ARM
ACY P
RO
GRAM
ME S
TRATEG
IC P
LAN
2017-2
020
PHARMACY PROGRAMME STRATEGIC PLAN
2017-20208
CU
STO
MER
EN
GA
GEM
EN
TTH
E QU
ALIT
Y OF
THE
CUS
TOM
ER E
XPER
IENC
E TH
AT E
MPH
ASIS
ES T
HE P
OSIT
IVE
ASPE
CTS
OF T
HE IN
TERA
CTIO
N W
ITH
OUR
ORGA
NISA
TION
Stra
tegy
Initi
ativ
eSt
rate
gy/In
itiat
ive
Deta
ilsPe
rfor
man
ce In
dica
tor
Targ
et b
y Ye
ar 2
020
STRA
TEGY
1:
Enha
nce
Mul
ti Se
ctor
En
gage
men
t Tow
ards
Be
tter H
ealth
Aw
aren
ess
Num
ber o
f Eng
agem
ent
Initi
ativ
e 1:
Enga
gem
ent w
ith lo
cal c
ounc
il in
redu
cing
una
ppro
ved
med
ical
ad
verti
sem
ent
To c
ondu
ct d
ialo
gue
sess
ions
fo
llow
ed b
y jo
ined
ope
ratio
ns
to w
ithdr
aw il
lega
l med
icin
e ad
verti
sem
ents
OPS
3B
Perc
enta
ge o
f PBT
cov
ered
100%
Initi
ativ
e 2:
Enga
gem
ent w
ith lo
cal m
edia
in
redu
cing
una
ppro
ved
med
ical
ad
verti
sem
ent
Enga
gem
ent w
ith lo
cal R
TM’s
radi
o st
atio
n th
roug
h di
alog
ue s
essi
onPe
rcen
tage
of l
ocal
RTM
’s ra
dio
stat
ion
cove
red
100%
Initi
ativ
e 3:
En
gagi
ng N
GOs/
prof
essi
onal
so
ciet
y/ g
over
nmen
t age
ncy
to
reac
h sp
ecifi
c gr
oup
tow
ards
qu
ality
use
of m
edic
ines
(QUM
) &
cust
omer
pro
tect
ion
This
initi
ativ
e is
focu
sing
on
eng
agem
ent w
ith N
GOs/
pr
ofes
sion
al s
ocie
ty/g
over
nmen
t ag
ency
as
a co
llabo
rativ
e ef
fort
to
educ
ate
and
incr
ease
aw
aren
ess
on
Qual
ity U
se o
f Med
icin
es
Num
ber o
f NGO
/soc
iety
/ go
vern
men
t age
ncy
enga
ged
(cum
ulat
ive)
5
STRA
TEGY
2:
Enha
nce
Valu
e Pr
opos
ition
of
Pha
rmac
y Se
rvic
es
This
initi
ativ
e ai
ms
to e
nhan
ce th
e pr
omot
ion
of p
harm
acy
serv
ices
1. C
usto
mer
Per
cept
ion
on
prof
essi
on a
nd s
ervi
ce2.
Ser
vice
Upt
ake
Rate
Incr
easi
ng tr
end
Initi
ativ
e 1:
Enha
nce
prom
otio
n of
pha
rmac
y se
rvic
es
This
initi
ativ
e ai
ms
to p
rom
ote
the
avai
labi
lity
of p
harm
acy
serv
ices
in
MOH
faci
lity
in o
rder
to im
prov
e se
rvic
e up
take
Impr
ove
com
mun
ity p
erce
ptio
n to
war
ds p
harm
acy
serv
ices
and
pr
ofes
sion
al im
age
Incr
ease
d co
mm
unity
aw
aren
ess
tow
ards
ph
arm
acy
serv
ices
STRATEG
IC T
HRU
STS A
ND
PLAN
OF A
CTIO
NS
9
INN
OVATIO
N D
RIV
EN
TRAN
SLAT
ING
IDEA
S AN
D IN
NOVA
TION
S IN
TO S
ERVI
CE T
HAT
CREA
TES
VALU
E FO
R OU
R CU
STOM
ERS
Stra
tegy
Initi
ativ
eSt
rate
gy/In
itiat
ive
Deta
ilsPe
rfor
man
ce In
dica
tor
Targ
et b
y Ye
ar 2
020
STRA
TEGY
1:
Impl
emen
tatio
n of
In
nova
tive
Phar
mac
y Se
rvic
e De
liver
y
Num
ber o
f inn
ovat
ive
phar
mac
y se
rvic
es d
eliv
ery
impl
emen
ted
by
year
202
02
Initi
ativ
e 1:
Expa
nsio
n of
Inte
grat
ed D
rug
Deliv
ery
Syst
em
This
initi
ativ
e ai
ms
to in
crea
se
patie
nt a
cces
s to
thei
r med
icin
e th
roug
h va
lue
adde
d se
rvic
e an
d en
surin
g co
ntin
uity
of t
heir
med
icat
ion
supp
ly
Num
ber o
f new
cen
tres
esta
blis
hed
(incr
easi
ng tr
end)
45 c
entre
s
Initi
ativ
e 2:
Med
icin
es O
ptim
isat
ion
This
initi
ativ
e fo
cuse
s on
pat
ient
s an
d th
eir e
xper
ienc
es w
ith th
e go
als
to h
elp
patie
nts
to im
prov
e tre
atm
ent o
utco
mes
and
avo
id
taki
ng u
nnec
essa
ry m
edic
ines
, re
duce
was
tage
as
wel
l as
impr
ove
med
icat
ion
safe
ty
Perc
enta
ge o
f med
ical
war
ds
impl
emen
ting
Patie
nt O
wn
Med
icat
ions
(POM
s) P
rogr
amm
es75
% o
f med
ical
war
d in
St
ate
and
Maj
or S
peci
alis
t Ho
spita
l25
% o
f med
ical
war
d in
M
inor
Spe
cial
ist H
ospi
tal
Perc
enta
ge o
f fac
ilitie
s im
plem
entin
g Pr
ogra
m B
ekas
Uba
tAl
l Sta
te h
ospi
tal
All M
ajor
Spe
cial
ist
Hosp
ital
26 M
inor
Spe
cial
ist
Hosp
ital
30%
of H
ealth
Clin
ics
STRA
TEGY
2:
ICT-
base
d Se
rvic
e In
nova
tion
No. o
f ICT
-bas
ed s
yste
m
deve
lope
d No
. of I
CT-b
ased
sys
tem
inte
grat
ed
19 in
depe
nden
t sys
tem
s de
velo
ped
3 in
tegr
ated
sys
tem
s
PHARMACY PROGRAMME STRATEGIC PLAN
2017-202010St
rate
gyIn
itiat
ive
Stra
tegy
/Initi
ativ
e De
tails
Perf
orm
ance
Indi
cato
rTa
rget
by
Year
202
0
Initi
ativ
e 1:
Busi
ness
Pro
cess
Ree
ngin
eerin
g (B
PR) o
f man
ual w
ork
proc
ess
to
ICT-
base
d
This
initi
ativ
e ai
ms
to im
prov
e ef
ficie
ncy
of s
ervi
ce d
eliv
ery
thro
ugh
trans
form
atio
n of
man
ual w
ork
proc
ess
into
onl
ine
base
d se
rvic
es
Num
ber o
f man
ual w
ork
proc
ess
inno
vate
d14
iden
tified
man
ual
proc
esse
s tra
nsfo
rmed
to
onlin
e ba
sed
serv
ice
Initi
ativ
e 2:
Inte
grat
ion
of IC
T-ba
sed
syst
ems
This
initi
ativ
e fo
cuse
s to
inte
grat
e 5
exis
ting
inde
pend
ent s
yste
ms
to im
prov
e sy
stem
s ef
ficie
ncy
and
optim
ise
data
sha
ring.
The
syst
ems
are:
- M
yPha
rma-
C-
SPIK
E-
QUES
T-
MER
s-
PhIS
/CPS
Inte
grat
ion
of th
e sy
stem
by
year
20
20
Inte
grat
ion
of :
1. M
ypha
rma-
C +
SPI
KE2.
MyP
harm
a-C
+ Q
UEST
pr
ojec
t 3.
QUE
ST +
PhI
S
Initi
ativ
e 3:
Impl
emen
tatio
n of
Ph
arm
aceu
tical
Trac
k &
Trac
e Sy
stem
Phar
mac
eutic
al Tr
ack
& Tr
ace
Syst
em is
an
initi
ativ
e to
impr
ove
patie
nt s
afet
y an
d op
timis
atio
n of
lo
gist
ic m
anag
emen
t
1st p
hase
Pha
rmac
eutic
al Tr
ack
& Tr
ace
Syst
em im
plem
ente
d by
the
year
201
9
1st p
hase
Pha
rmac
eutic
al
Trac
k &
Trac
e Sy
stem
im
plem
ente
d by
the
year
20
19
Initi
ativ
es 4
: Op
timis
atio
n of
PhI
S in
MOH
fa
cilit
ies
PhIS
is a
web
-bas
ed d
rug
man
agem
ent s
yste
m to
be
fully
ut
ilised
in a
ll M
OH fa
cilit
ies
by th
e ye
ar 2
020
Perc
enta
ge o
f ARU
(A
vaila
bilit
y, Re
liabi
lity
and
Utilis
atio
n)
100%
ava
ilabi
lity
95%
relia
bilit
y(U
tilis
atio
n: in
crem
enta
l tre
nd 2
018-
2020
)
STRA
TEGY
3:
Enha
nce
Rese
arch
and
Kn
owle
dge
Shar
ing
Num
ber o
f arti
cles
/tech
nica
l re
ports
pub
lishe
d60
arti
cles
/tech
nica
l re
ports
(incr
emen
tal t
rend
2017
-202
0)
11St
rate
gyIn
itiat
ive
Stra
tegy
/Initi
ativ
e De
tails
Perf
orm
ance
Indi
cato
rTa
rget
by
Year
202
0
Initi
ativ
e 1:
Inte
nsify
rese
arch
bas
ed o
n pr
iorit
y ar
ea id
entifi
ed
This
initi
ativ
e ai
ms
to e
ncou
rage
ph
arm
acis
ts/p
harm
acy
assi
stan
ts
to c
ondu
ct re
sear
ches
bas
ed o
n Ph
arm
acy
Prog
ram
me
Rese
arch
Pr
iorit
y Fr
amew
ork
(Sta
ndar
d, Ye
ar 2
015:
50%
)
Perc
enta
ge o
f pha
rmac
y fa
cilit
ies
with
in M
OH c
ondu
ctin
g re
sear
ch
95%
pha
rmac
y fa
cilit
ies
cond
uctin
g re
sear
ch
Initi
ativ
e 2:
Inte
nsify
kno
wle
dge
shar
ing
in re
sear
ch th
roug
h m
ultip
le
plat
form
s
This
initi
ativ
e ai
ms
to in
tens
ify
know
ledg
e sh
arin
g in
rese
arch
. Re
sear
ches
are
enc
oura
ged
to b
e pr
esen
ted
in v
ario
us p
latfo
rms
(loca
l an
d in
tern
atio
nal l
evel
)
Num
ber o
f res
earc
h pr
esen
ted
370
rese
arch
es p
rese
nted
(incr
emen
tal t
rend
2017
-202
0)
STRA
TEGY
4:
Enha
nce
Busi
ness
Pro
cess
an
d Pr
oduc
t Saf
ety
Num
ber o
f priv
ate
labo
rato
ries
reco
gnis
ed5
priv
ate
labo
rato
ries
reco
gnis
ed
Initi
ativ
e 1:
Reco
gniti
on o
f priv
ate
labo
rato
ries
(con
duct
ing
test
for
tradi
tiona
l pro
duct
s)
This
initi
ativ
e ai
ms
to re
cogn
ise
priv
ate
labo
rato
ries
with
the
capa
citie
s to
pro
vide
test
ing
for;
- He
avy
Met
al
- M
icro
bial
Con
tam
inat
ion
- Un
iform
ity o
f Wei
ght
- Di
sint
egra
tion
Num
ber o
f priv
ate
labo
rato
ries
reco
gnis
ed
5 pr
ivat
e la
bora
torie
s re
cogn
ised
Initi
ativ
e 2:
Priv
atis
atio
n of
pre
-reg
istra
tion
test
ing
for t
radi
tiona
l pro
duct
This
initi
ativ
e w
ill en
able
NPR
A to
re
depl
oy re
sour
ces
for n
ew s
ervi
ces
Regi
stra
tion
test
ing
for t
radi
tiona
l pr
oduc
ts fu
lly c
ondu
cted
by
reco
gnis
ed p
rivat
e la
bora
torie
s by
202
0
All r
egis
tratio
n te
stin
g co
nduc
ted
by p
rivat
e la
bora
torie
s by
yea
r 202
0
PHARMACY PROGRAMME STRATEGIC PLAN
2017-202012
OPER
ATIO
NA
L E
XC
ELLEN
CE
THE
ELEM
ENT
OF O
RGAN
ISAT
IONA
L LE
ADER
SHIP
THA
T AP
PLIE
S A
VARI
ETY
OF P
RINC
IPLE
S, S
YSTE
MS
AND
TOOL
S TO
WAR
DTH
E SU
STAI
NABL
E IM
PROV
EMEN
TOF
KEY
PERF
ORM
ANCE
MET
RICS
Stra
tegy
Initi
ativ
eSt
rate
gy/In
itiat
ive
Deta
ilsPe
rfor
man
ce In
dica
tor
Targ
et b
y Ye
ar 2
020
STRA
TEGY
1:
Impr
ove
Acce
ssib
ility
of
Phar
mac
eutic
al P
rodu
cts
Impl
emen
tatio
n of
Pric
e Se
tting
m
echa
nism
and
pat
ient
acc
ess
sche
me
Both
initi
ated
and
im
plem
ente
d
Initi
ativ
e 1:
Impl
emen
tatio
n of
Pric
e Se
tting
m
echa
nism
Pric
e Se
tting
for m
edic
ines
will
be
done
thro
ugh
the
deve
lopm
ent o
f a
mec
hani
sm fo
r pric
e se
tting
in
coop
erat
ion
with
rele
vant
aut
horit
ies
Pric
e Se
tting
mec
hani
sm is
im
plem
ente
dPr
ice
Setti
ng M
echa
nism
s is
impl
emen
ted
by 2
019
Co
nsum
er M
edic
ine
Pric
e is
pub
lishe
d by
201
9
Initi
ativ
e 2:
Impr
ovin
g ac
cess
to a
fford
able
m
edic
ine
thro
ugh
patie
nt a
cces
s sc
hem
e (P
AS)
This
pro
gram
me
is d
esig
ned
to
impr
ove
patie
nt a
cces
s to
hig
h co
st
med
icin
es
Num
ber o
f pat
ient
acc
ess
sche
me
(PAS
) im
plem
ente
d2
sche
mes
impl
emen
ted
STRA
TEGY
2:
Impr
ove
Effic
ienc
y &
Optim
ise
Expe
nditu
re
Perc
enta
ge o
f dos
sier
rece
ived
w
ith lo
cal P
E st
udy
(10%
by
2020
)10
% o
f dos
sier
rece
ived
w
ith lo
cal P
E st
udy
Initi
ativ
e 1:
Utilis
atio
n of
loca
l Ph
arm
acoe
cono
mic
[PE]
dat
a in
the
sele
ctio
n of
med
icin
es fo
r fo
rmul
ary
listin
g
This
initi
ativ
e ai
ms
to e
ncou
rage
ph
arm
acoe
cono
mic
stu
dies
util
isin
g lo
cal d
ata
thro
ugh
esta
blis
hmen
t of
PE C
entre
Perc
enta
ge o
f dos
sier
rece
ived
w
ith lo
cal P
E st
udy
(10%
by
2020
)10
% o
f dos
sier
rece
ived
w
ith lo
cal P
E st
udy
STRA
TEGY
3:
Stre
ngth
en m
onito
ring
activ
ities
of u
nreg
iste
red
prod
ucts
No. o
f lic
ence
s pr
emis
e an
d m
edia
pl
atfo
rm m
onito
red
13St
rate
gyIn
itiat
ive
Stra
tegy
/Initi
ativ
e De
tails
Perf
orm
ance
Indi
cato
rTa
rget
by
Year
202
0
Initi
ativ
e 1:
Expa
nd th
e “D
idik
, Pan
tau
and
Serb
u (D
iPS)
” ap
proa
ch to
the
hots
pot a
reas
DiPS
: Did
ik, P
anta
u an
d Se
rbu
is
a sy
stem
atic
app
roac
h to
redu
ce
sale
s of
unr
egis
tere
d pr
oduc
ts
thro
ugh
awar
enes
s an
d su
rvei
llanc
e am
ongs
t ret
aile
rs
Perc
enta
ge o
f tar
gete
d pr
emis
es
sellin
g un
regi
ster
ed p
rodu
cts
Redu
ctio
n of
targ
eted
pr
emis
es s
ellin
g un
regi
ster
ed p
rodu
cts
by
80%
in y
ear 2
020
Initi
ativ
e 2:
Mon
itorin
g s
ales
of u
nreg
iste
red
prod
ucts
and
cos
met
ics
in
the
soci
al m
edia
and
inst
ant
mes
sagi
ng p
latfo
rms
A so
cial
med
ia a
nd in
stan
t m
essa
ging
(IM
) pla
tform
is a
W
eb-b
ased
tech
nolo
gy th
at e
nabl
es
the
deve
lopm
ent,
depl
oym
ent a
nd
man
agem
ent o
f soc
ial m
edia
and
in
stan
t mes
sagi
ng s
olut
ions
and
se
rvic
es
The
num
ber o
f soc
ial m
edia
pl
atfo
rms
and
IM p
latfo
rms
mon
itore
d 25
pla
tform
s m
onito
red
STRA
TEGY
4:
Stre
ngth
en G
over
nanc
e &
Regu
lato
ry C
ontro
l
Esta
blis
hmen
t of N
PRA
as a
ce
rtifie
d Co
nfor
mity
Ass
essm
ent
Body
(CAB
) by
2018
Initi
ativ
e 1:
Esta
blis
hmen
t of N
PRA
as a
ce
rtifie
d Co
nfor
mity
Ass
essm
ent
Body
(CAB
)
This
initi
ativ
e ai
ms
to e
nhan
ce
regu
lato
ry c
ontro
l and
gov
erna
nce
of
NPRA
in m
edic
al d
evic
e
Certi
ficat
ion
as a
CAB
Certi
fied
as a
CAB
by
Med
ical
Dev
ice
Auth
ority
by
201
8
Initi
ativ
e 2:
En
hanc
e Re
gula
tory
Con
trol
of V
acci
ne in
the
Aspe
cts
of
Labo
rato
ry Te
stin
g
This
initi
ativ
e ai
ms
to e
nhan
ce
regu
lato
ry c
ontro
l in
vacc
ine
thro
ugh
colla
bora
tion
with
iden
tified
par
tner
in
dev
elop
ing
vacc
ine
test
ing
met
hod
Vacc
ine
test
ing
met
hod
deve
lope
dTh
ree
(3) v
acci
ne te
stin
g m
etho
d de
velo
ped
by
2018
STRA
TEGY
5:
Enha
nce
Orga
nisa
tiona
l Ef
ficie
ncy
Esta
blis
hmen
t NPR
A an
d LF
M a
s St
atut
ory
Body
Fina
lisat
ion
of B
ill by
202
0
PHARMACY PROGRAMME STRATEGIC PLAN
2017-202014St
rate
gyIn
itiat
ive
Stra
tegy
/Initi
ativ
e De
tails
Perf
orm
ance
Indi
cato
rTa
rget
by
Year
202
0
Initi
ativ
e 1:
Esta
blis
hmen
t of N
atio
nal
Phar
mac
eutic
al R
egul
ator
y Ag
ency
(NPR
A) a
s a
stat
utor
y bo
dy
This
initi
ativ
e fo
cuse
s on
en
hanc
ing
NPRA
effi
cien
cy th
roug
h es
tabl
ishm
ent a
s st
atut
ory
body
Fina
lisat
ion
of b
ill
Fina
lisat
ion
of b
ill as
a
stat
utor
y bo
dy b
y 20
20
Initi
ativ
e 2:
Esta
blis
hmen
t of M
alay
sia
Phar
mac
y Bo
ard
(LFM
) as
a st
atut
ory
body
This
initi
ativ
e fo
cuse
s on
en
hanc
ing
LFM
effi
cien
cy th
roug
h es
tabl
ishm
ent a
s st
atut
ory
body
Fina
lisat
ion
of b
ill
Fina
lisat
ion
of b
ill as
a
stat
utor
y bo
dy b
y 20
20
CA
PA
BIL
ITY B
UIL
DIN
GPR
OCES
S OF
DEV
ELOP
ING
AND
STRE
NGTH
ENIN
G TH
E SK
ILLS
, ABI
LITI
ES A
ND R
ESOU
RCES
THA
TOR
GANI
SATI
ONS
NEED
TO
ADAP
T AN
D TH
RIVE
IN A
CHA
NGIN
G EN
VIRO
NMEN
T
Stra
tegy
Initi
ativ
eSt
rate
gy/In
itiat
ive
Deta
ilsPe
rfor
man
ce In
dica
tor
Targ
et b
y Ye
ar 2
020
STRA
TEGY
1:
Enha
nce
Hum
an R
esou
rce
Com
pete
ncy
and
Perfo
rman
ce
Capa
bilit
y bu
ildin
g Fr
amew
ork
deve
lope
dFr
amew
ork
com
plet
ed
by 2
019
Initi
ativ
e 1:
Deve
lop
capa
bilit
y bu
ildin
g fra
mew
ork
(tech
nica
l &
man
agem
ent)
This
initi
ativ
e ai
ms
to d
evel
op a
fra
mew
ork
that
offe
r an
over
view
of
the
vario
us c
aree
r opt
ions
alo
ng w
ith
educ
atio
n an
d tra
inin
g
Capa
bilit
y bu
ildin
g fra
mew
ork
deve
lope
dFr
amew
ork
deve
lope
d by
ye
ar 2
020
15St
rate
gyIn
itiat
ive
Stra
tegy
/Initi
ativ
e De
tails
Perf
orm
ance
Indi
cato
rTa
rget
by
Year
202
0
Initi
ativ
e 2:
Expa
nsio
n of
cre
dent
ialin
g an
d pr
ivile
ging
(C&P
) act
ivity
C&P
is a
pro
gram
to c
rede
ntia
l qu
alifi
ed in
divi
dual
s in
iden
tified
ar
eas
of p
ract
ice
Area
of P
ract
ice:
- En
forc
emen
t (Cy
ber F
oren
sic)
- Cl
inic
al-
Phar
mac
y Pr
actic
e-
R&D
- Re
gula
tory
1. N
o. o
f ide
ntifi
ed a
reas
of p
ract
ice
esta
blis
hed
2. N
o. o
f qua
lified
pha
rmac
ists
be
ing
cred
entia
led
C&P
esta
blis
hed
for a
ll id
entifi
ed a
rea
of p
ract
ice
30 q
ualifi
ed p
harm
acis
ts
cred
entia
led
Initi
ativ
e 3:
Esta
blis
hmen
t of S
ubje
ct M
atte
r Ex
pert
(SM
E) P
rogr
amm
e in
ph
arm
acy
serv
ices
Subj
ect M
atte
r Exp
ert i
s a
form
of
reco
gniti
on to
an
indi
vidu
al
phar
mac
ist w
ho is
an
expe
rt in
a
parti
cula
r are
a/fie
ld
Esta
blis
hmen
t of S
ubje
ct M
atte
r Ex
pert
(SM
E) P
rogr
amm
e in
ph
arm
acy
SME
prog
ram
est
ablis
hed
by 2
020
Initi
ativ
e 4:
Enha
nce
offic
ers’
cap
abilit
y to
car
ry o
ut a
nalys
is of
dig
ital
evid
ence
(Cyb
er F
oren
sic
Labo
rato
ry)
To c
ondu
ct a
spe
cial
trai
ning
with
ac
cred
ited
fore
nsic
age
ncy
Num
ber o
f offi
cers
und
ergo
trai
ning
an
d ce
rtifie
d10
0% o
ffice
rs c
ertifi
ed in
ad
vanc
ed le
vel
STRA
TEGY
2:
Optim
ise
Hum
an R
esou
rce
Capa
city
to E
nsur
e Co
ntin
uous
Ser
vice
Del
iver
y
Perc
enta
ge o
f MOH
faci
litie
s ac
hiev
ed m
ore
than
80%
pos
ts
fille
d80
%
Initi
ativ
e 1:
Deve
lop
Staf
fing
Guid
elin
es b
ased
on
faci
lity
wor
kloa
d
Iden
tifyi
ng th
e st
affin
g ne
eds
usin
g W
orkl
oad
Indi
cato
r for
Sta
ffing
Nee
ds
(WIS
N)
Staf
fing
guid
elin
es d
evel
oped
Staf
fing
guid
elin
es
deve
lope
d by
202
0
Initi
ativ
e 2:
Rede
ploy
men
t of p
harm
acy
staf
f to
ach
ieve
a b
alan
ced
WIS
N ra
tio
To e
nsur
e nu
mbe
r of f
acilit
ies
(hos
pita
l & h
ealth
clin
ics)
ach
ievi
ng
bala
nce
WIS
N ra
tio o
f 1 o
r agr
eed
ratio
(WIS
N ra
tio o
f 1 in
dica
tes
bala
nced
w
orkl
oad
and
man
pow
er)
Perc
enta
ge o
f fac
ility
achi
evin
g th
e ag
reed
ratio
or W
ISN
ratio
of 1
Mor
e th
an 7
5% o
f fac
ility
achi
eved
the
agre
ed ra
tio
or W
ISN
ratio
of 1
PHARMACY PROGRAMME STRATEGIC PLAN
2017-202016
Pharmacy Policy and Strategic Planning Division would like to express gratitude and appreciation to the following participants for their support and contribution in the preparation of this document. The success and final outcome of this document required a lot of guidance and assistance from many people and we were extremely fortunate to have this all along until the completion of the document.
• Pharmacy Practice and Development Division• Pharmacy Enforcement Division• National Pharmaceutical Regulatory Agency (NPRA)• Pharmacy Board Malaysia• Deputy Director (Pharmacy) State Health Department • State Pharmacy Representatives
ACKNOWLEDGEMENT
17
PHARMACY PROGRAMME STRATEGIC PLAN
2017-202018
www.pharmacy.gov.my
PHARMACEUTICAL SERVICES DIVISIONMinistry of Health MalaysiaLot 36, Jalan Universiti46350 Petaling JayaSelangor
T 03-7841 3200 F 03-7968 2222
PHARMACEUTICAL SERVICES DIVISIONMinistry of Health Malaysia
PHARMACYPROGRAMMESTRATEGIC PLAN